Actual Medicinal Product (AMP) - Mirvaso 3mg/g gel (Galderma (UK) Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Mirvaso 3mg/g gel | Start Date 12-03-2014 | End Date |
Summary
- Licensed Route
- Cutaneous
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 13060300 | Start Date 25-06-2014 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 24111711000001107 | 12-03-2014 |
Parent Products
-
VTMBrimonidine
-
VMPBrimonidine 3mg/g gel
-
AMP(Current) Mirvaso 3mg/g gel (Galderma (U... (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 30 gram | 3369 |